FSAs often require a letter of medical necessity that explains why treatment is needed
Each battery can have different C ratings
Early GHK-Cu peptide results look most promising when it is combined with therapies like PRP, exosomes, or low-level laser in carefully selected patients
Abstract Tirzepatide, a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has shown robust efficacy in treating diabetes and obesity, and in obese patients with heart failure with preserved ejection fraction (HFpEF), it reduced weight, lowered blood pressure, and improved outcomes
It is meant for patients with a BMI of over 30, or patients who have a BMI over 27 with a weight-related health complication (sleep apnea, high cholesterol, etc.)
As a result, the livers ability to produce the master antioxidant, glutathione, is reduced leading to oxidative damage, fatigue, and premature aging